BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26242884)

  • 1. Gangrenous Cholecystitis Related to Transcatheter Arterial Chemoembolization (TACE) Treatment for Hepatocellular Carcinoma.
    Karavias D; Kourea H; Sotiriadi A; Karnabatidis D; Karavias D
    J Gastrointest Surg; 2015 Nov; 19(11):2093-5. PubMed ID: 26242884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
    Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization alone before major hepatectomy for patients with large hepatocellular carcinoma: An intent-to-treat analysis.
    Terasawa M; Allard MA; Golse N; Sa Cunha A; Cherqui D; Adam R; Saiura A; Vibert E
    Surgery; 2020 Feb; 167(2):425-431. PubMed ID: 31780050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ischemic cholecystitis caused by arterial chemoembolization of hepatocellular carcinoma].
    De Diego A; Santos L; Vaquero J; Salcedo M; Ramos A; García Durán F; Rincón D; Cos E; Clemente G
    Rev Esp Enferm Dig; 1999 Jan; 91(1):74-5. PubMed ID: 10089791
    [No Abstract]   [Full Text] [Related]  

  • 5. Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
    Zhang L; Sun JH; Ji JS; Zhong BY; Zhou GH; Song JJ; Hou ZH; Huang P; Zhang S; Li Z; Zhu XL; Ni CF
    AJR Am J Roentgenol; 2021 Oct; 217(4):933-943. PubMed ID: 33245680
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
    Li J; Wang N; Shi C; Liu Q; Song J; Ye X
    J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gallbladder Perforation after Transarterial Chemoembolization in a Patient with a Huge Hepatocellular Carcinoma].
    Son MY; Han BH; Lee SU; Yun BC; Seo KI; Huh JD
    Korean J Gastroenterol; 2020 Jun; 75(6):351-355. PubMed ID: 32581207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute ischemic cholecystitis after transarterial chemoembolization of hepatocellular carcinoma: incidence and clinical outcome.
    Wagnetz U; Jaskolka J; Yang P; Jhaveri KS
    J Comput Assist Tomogr; 2010; 34(3):348-53. PubMed ID: 20498534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effect of terminal branches portal vein embolization combined with transcatheter arterial chemoembolization on liver neoplasms].
    Peng SY; Huang CY; Wang XA; Wang YF; Zhang YY; Li JT; Xu B; Liang X; Wang JW; Hong DF; Cai XJ
    Zhonghua Wai Ke Za Zhi; 2017 Sep; 55(9):655-660. PubMed ID: 28870049
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus.
    Zhang YF; Wei W; Guo ZX; Wang JH; Shi M; Guo RP
    Jpn J Clin Oncol; 2015 Sep; 45(9):837-43. PubMed ID: 26079139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE).
    Nakano MM; Yamamoto A; Nishida N; Hamuro M; Hamamoto S; Jogo A; Sohgawa E; Kageyama K; Minami T; Miki Y
    Jpn J Radiol; 2019 Jul; 37(7):543-548. PubMed ID: 31055710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Arterio-Portal Shunt Formation after Drug-Eluting Beads TACE for Hepatocellular Carcinoma.
    Shimose S; Iwamoto H; Tanaka M; Niizeki T; Shirono T; Nakano M; Okamura S; Noda Y; Kamachi N; Sakai M; Suzuki H; Nomiyama M; Kuromatsu R; Koga H; Torimura T
    Oncology; 2020; 98(8):558-565. PubMed ID: 32422633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
    Xiang H; Long L; Yao Y; Fang Z; Zhang Z; Zhang Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819830751. PubMed ID: 30862264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma.
    Park GC; Lee SG; Yoon YI; Sung KB; Ko GY; Gwon DI; Jung DH; Jung YK
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):244-251. PubMed ID: 32414576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
    BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.
    Gorodetski B; Chapiro J; Schernthaner R; Duran R; Lin M; Lee H; Lenis D; Stuart EA; Nonyane BA; Pekurovsky V; Tamrazi A; Gebauer B; Schlachter T; Pawlik TM; Geschwind JF
    Eur Radiol; 2017 Feb; 27(2):526-535. PubMed ID: 27277261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus.
    Minagawa M; Makuuchi M; Takayama T; Ohtomo K
    Ann Surg; 2001 Mar; 233(3):379-84. PubMed ID: 11224626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
    Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
    Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.